Gardi M - Search Results

1

Immunotherapy and urothelial carcinoma: An overview and future prospectives.

Pierantoni F, Maruzzo M, Gardi M, Bezzon E, Gardiman MP, Porreca A, Basso U, Zagonel V. Pierantoni F, et al. Among authors: gardi m. Crit Rev Oncol Hematol. 2019 Nov;143:46-55. doi: 10.1016/j.critrevonc.2019.08.005. Epub 2019 Aug 26. Crit Rev Oncol Hematol. 2019. PMID: 31476551 Review.

2

Recurrent nephrogenic adenoma in bladder diverticulum: Case report and literature review.

Boscolo-Berto R, Lamon C, Gardi M, Vezzaro R, Gardiman M. Boscolo-Berto R, et al. Among authors: gardi m. Can Urol Assoc J. 2012 Apr;6(2):E34-7. doi: 10.5489/cuaj.10140. Can Urol Assoc J. 2012. PMID: 22511428 Free PMC article.

3

Peripheral primitive neuroectodermal tumor of seminal vesicles: is there a role for relatively aggressive treatment modalities?

Crestani A, Guttilla A, Gardi M, Gardiman M, Dal Moro F, Valotto C, Zattoni F. Crestani A, et al. Among authors: gardi m. Arch Ital Urol Androl. 2014 Dec 30;86(4):291-2. doi: 10.4081/aiua.2014.4.291. Arch Ital Urol Androl. 2014. PMID: 25641454 Free article.

4

Oligometastatic recurrent prostate cancer detects by fluorine-18-choline positron emission tomography/computed tomography in patients with prostate-specific antigen levels of up to 5 ng/ml.

Evangelista L, Cuppari L, Guttilla A, Gardi M, Agostini A, Ruggera L, Basso U, Saladini G. Evangelista L, et al. Among authors: gardi m. Nucl Med Commun. 2018 Mar;39(3):260-267. doi: 10.1097/MNM.0000000000000808. Nucl Med Commun. 2018. PMID: 29381584

5

von Hippel-Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement.

Gardi M, Basso U, Ferrara AM, Zovato S, Feletti A, Watutantrige-Fernando S, Dal Moro F, Opocher G; VHL-Padova Network. Gardi M, et al. Cancer. 2022 Nov 15;128(22):4027-4028. doi: 10.1002/cncr.34460. Epub 2022 Sep 28. Cancer. 2022. PMID: 36169342 Free article. No abstract available.

6

Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasia.

Pinto F, Racioppi M, Sacco E, Totaro A, Brescia A, Volpe A, Gardi M, Bassi PF. Pinto F, et al. Among authors: gardi m. Arch Ital Urol Androl. 2009 Mar;81(1):1-8. Arch Ital Urol Androl. 2009. PMID: 19499750 Review.

7

Complications in nephron-sparing renal surgery: from description to prediction.

Boscolo-Berto R, Gardi M, Galfano A. Boscolo-Berto R, et al. Among authors: gardi m. Int J Urol. 2010 Jul;17(7):683. doi: 10.1111/j.1442-2042.2010.02560.x. Epub 2010 May 25. Int J Urol. 2010. PMID: 20500536 No abstract available.

8

Von Hippel-Lindau disease: an evaluation of natural history and functional disability.

Feletti A, Anglani M, Scarpa B, Schiavi F, Boaretto F, Zovato S, Taschin E, Gardi M, Zanoletti E, Piermarocchi S, Murgia A, Pavesi G, Opocher G. Feletti A, et al. Among authors: gardi m. Neuro Oncol. 2016 Jul;18(7):1011-20. doi: 10.1093/neuonc/nov313. Epub 2016 Jan 12. Neuro Oncol. 2016. PMID: 26763786 Free PMC article.

9

Von Hippel-Lindau disease and multispecialist team.

Pavesi G, Feletti A, Ferrara AM, Anglani M, Scarpa B, Schiavi F, Boaretto F, Zovato S, Taschin E, Gardi M, Zanoletti E, Piermarocchi S, Murgia A, Opocher G; VHL-Padova Network. Pavesi G, et al. Among authors: gardi m. J Neurosurg Sci. 2021 Apr;65(2):213-215. doi: 10.23736/S0390-5616.20.04950-4. Epub 2020 Apr 29. J Neurosurg Sci. 2021. PMID: 32347679 No abstract available.

10

New therapeutical approaches for non muscle invasive bladder cancer.

Volpe A, Racioppi M, Sacco E, Bongiovanni L, D'Agostino D, Cappa E, Pinto F, Gardi M, Totaro A, Bassi P. Volpe A, et al. Among authors: gardi m. Arch Ital Urol Androl. 2008 Dec;80(4):136-42. Arch Ital Urol Androl. 2008. PMID: 19235429 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page